Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 47 device-driven procedures, CMS 2024
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 39 | 2,381−1.7%/yr | −1.7%/yr | 6.11.0× | 34% | 2,430 in 2030+0.3%/yr |
| Tumor & fibroid embolization |
How the numbers are made · Every state · Compare two markets
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
| 6 |
| 355+8.7%/yr |
| +8.7%/yr |
| 0.91.5× |
| 30% |
| 460 in 2030+4.5%/yr |
| Tumor ablation | 0 | 120+0.7%/yr | +0.7%/yr | 0.31.1× | 0% | 140 in 2030+2.7%/yr |
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.